Search by Drug Name or NDC
NDC 65219-0164-50 Calcium Gluconate 20 mg/mL Details
Calcium Gluconate 20 mg/mL
Calcium Gluconate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is CALCIUM GLUCONATE MONOHYDRATE.
Product Information
| NDC | 65219-0164 |
|---|---|
| Product ID | 65219-164_8c1018aa-9049-4a9c-a553-a76a7630f17a |
| Associated GPIs | 79109902192007 |
| GCN Sequence Number | 079278 |
| GCN Sequence Number Description | calcium gluc in NaCl, iso-osm PLAST. BAG 2 G/100 ML INTRAVEN |
| HIC3 | C1F |
| HIC3 Description | CALCIUM REPLACEMENT |
| GCN | 45748 |
| HICL Sequence Number | 045482 |
| HICL Sequence Number Description | CALCIUM GLUCONATE IN SODIUM CHLORIDE, ISO-OSMOTIC |
| Brand/Generic | Generic |
| Proprietary Name | Calcium Gluconate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Calcium Gluconate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | CALCIUM GLUCONATE MONOHYDRATE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208418 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65219-0164-50 (65219016450)
| NDC Package Code | 65219-164-50 |
|---|---|
| Billing NDC | 65219016450 |
| Package | 24 BAG in 1 CASE (65219-164-50) / 100 mL in 1 BAG (65219-164-01) |
| Marketing Start Date | 2021-06-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |